Pharmacokinetics
Target serum concentrations of ravulizumab (> 175 µg/mL) [Mean (SD) concentration–time profile of ravulizumab over 26 weeks. Target serum concentrations of ravulizumab (> 175 µg/mL) were achieved immediately after the first dose and sustained throughout the entire 26-week treatment period. Mean (SD) ravulizumab 